Anti-malarial drugs

Poojasalve24 Feb, 2022Other

High prevalence of malaria around the world is primarily boosting demand for Anti-Malarial Drugs. In 2020 an estimated 241 million cases of malaria occurred worldwide and 627,000 people died, mostly children in sub-Saharan Africa. About 2,000 cases of malaria are diagnosed in the U.S annually. Several companies are focused on approval and launch of new drugs for the treatment of malaria. In May 2020, The U.S. Food and Drug Administration approved artesunate for injection to treat severe malaria in adult and pediatric patients. Recently, in December 2021, Zydus Cadila, Indian multinational pharmaceutical company, received Orphan Drug Designation for ZY19489 (MMV253), an antimalarial compound.